Webinar: Assessing Clinical and Economic Benefits of Biocomputational Models

27 March 2012, 09:00 PDST/13:00 EST/18:00 CEST (UTC +02:00).
The economic assessment method described reflects the latest research from the NMS Physiome project, a cooperation of two of the largest global research projects focusing on predictive, personalised and integrative musculoskeletal medicine: the Osteoporotic Virtual Physiological Human (VPHOP) project, and the Center for Physics-based Simulation of Biological Structures (SIMBIOS) at Stanford University.

The Virtual Physiological Human (VPH) is a framework of methods and technologies that, once fully established, is expected to make possible the virtual investigation of the human body as a whole. Started in Europe in 2005, it has rapidly grown to become one of the research priorities of the Information and Communication Technologies Programme of the EU Seventh Framework Programme for Research and Technological Development, which runs from 2007 to 2013. In the US, VPH-type research is funded by all the federal agencies that participate in the Interagency Modeling and Analysis Group (IMAG), whose grantees are coordinated in the Multi-Scale Modeling (MSM) consortium.

NMS Physiome is an international project co-funded by the European Commission Seventh Framework Programme for Research and Technological Development. The Webinar is hosted by SIMBIOS, Stanford University.

How do you assess the impact of biocomputational models?
Karl Stroetmann and Rainer Thiel, empirica Communication and Technology Research, Bonn, Germany.

In this webinar, you will learn about general principles to evaluate the prospective economic and clinical benefits of simulation methods. Webinar organisers will show how this approach enables you to:

  • Assess simulation research and translate technical capability into quantitative estimates of costs and benefits that go beyond model validation
  • Gain a better understanding about the impact such work can have on future health care service delivery and clinical practice
  • Demonstrate the added value of simulation research through clear measures of clinical benefits and the development of business cases
  • More effectively decide what aspects of the model should be included or excluded

The webinar is targeted at biocomputational modellers and researchers as well as RTD funding agencies in the field of Virtual Physiological Human and Physiome.

Duration: 60 minutes.

To register for the event, please visit:
https://stanford.webex.com/stanford/onstage/g.php?d=925320571&t=a

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

Testing AI with AI: Ensuring Effective A…

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...